UnitedHealth Historical Income Statement
| UNH Stock | USD 590.87 6.62 1.11% |
Historical analysis of UnitedHealth Group income statement accounts such as Depreciation And Amortization of 4.2 B, Total Revenue of 390.2 B, Gross Profit of 91.2 B or Other Operating Expenses of 356.2 B can show how well UnitedHealth Group Incorporated performed in making a profits. Evaluating UnitedHealth Group income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of UnitedHealth Group's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining UnitedHealth Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether UnitedHealth Group is a good buy for the upcoming year.
UnitedHealth |
About UnitedHealth Income Statement Analysis
UnitedHealth Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to UnitedHealth Group shareholders. The income statement also shows UnitedHealth investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
UnitedHealth Group Income Statement Chart
Add Fundamental
Gross Profit
Gross profit is a required income statement account that reflects total revenue of UnitedHealth Group Incorporated minus its cost of goods sold. It is profit before UnitedHealth Group operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of UnitedHealth Group. It is also known as UnitedHealth Group overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from UnitedHealth Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of UnitedHealth Group Incorporated is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from UnitedHealth Group's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into UnitedHealth Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. As of now, UnitedHealth Group's Other Operating Expenses is increasing as compared to previous years. The UnitedHealth Group's current Operating Income is estimated to increase to about 34 B, while Total Other Income Expense Net is forecasted to increase to (3.1 B).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 285.3B | 322.1B | 371.6B | 390.2B | Depreciation And Amortization | 3.1B | 3.4B | 4.0B | 4.2B |
UnitedHealth Group income statement Correlations
Click cells to compare fundamentals
UnitedHealth Group Account Relationship Matchups
High Positive Relationship
High Negative Relationship
UnitedHealth Group income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 2.7B | 2.9B | 3.1B | 3.4B | 4.0B | 4.2B | |
| Total Revenue | 240.3B | 255.6B | 285.3B | 322.1B | 371.6B | 390.2B | |
| Gross Profit | 55.7B | 65.5B | 67.3B | 77.6B | 86.9B | 91.2B | |
| Other Operating Expenses | 222.5B | 234.7B | 263.6B | 295.7B | 339.3B | 356.2B | |
| Operating Income | 19.7B | 22.4B | 24.0B | 28.4B | 32.4B | 34.0B | |
| Ebit | 17.8B | 22.4B | 24.0B | 28.4B | 32.4B | 34.0B | |
| Ebitda | 20.5B | 25.3B | 27.1B | 31.8B | 36.3B | 38.1B | |
| Cost Of Revenue | 184.6B | 190.1B | 217.9B | 244.5B | 284.8B | 299.0B | |
| Total Operating Expenses | 37.9B | 44.6B | 45.7B | 51.2B | 339.3B | 356.2B | |
| Income Before Tax | 18.0B | 20.7B | 22.3B | 26.3B | 29.1B | 30.6B | |
| Total Other Income Expense Net | (1.7B) | (1.7B) | (1.7B) | (2.1B) | (3.2B) | (3.1B) | |
| Net Income | 13.8B | 15.4B | 17.3B | 20.1B | 22.4B | 23.5B | |
| Income Tax Expense | 3.7B | 5.0B | 4.6B | 5.7B | 6.0B | 6.3B | |
| Interest Expense | 1.7B | 1.7B | 1.7B | 2.1B | 3.2B | 3.4B | |
| Selling General Administrative | 35.2B | 41.7B | 42.6B | 47.8B | 54.9B | 57.7B | |
| Net Income Applicable To Common Shares | 13.8B | 15.4B | 17.3B | 20.1B | 23.1B | 24.3B | |
| Net Income From Continuing Ops | 14.2B | 15.8B | 17.7B | 20.6B | 23.1B | 11.6B | |
| Minority Interest | 400M | 366M | (447M) | (519M) | (763M) | (724.9M) | |
| Tax Provision | 3.7B | 5.0B | 4.6B | 5.7B | 6.0B | 5.0B | |
| Interest Income | 1.7B | 1.7B | 1.7B | 2.1B | 2.4B | 1.6B | |
| Net Interest Income | (1.7B) | (1.7B) | (1.7B) | (2.1B) | (3.2B) | (3.1B) | |
| Reconciled Depreciation | 2.7B | 2.9B | 3.1B | 3.4B | 4.0B | 3.3B |
Currently Active Assets on Macroaxis
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.043 | Dividend Share 7.96 | Earnings Share 15.36 | Revenue Per Share 427.221 | Quarterly Revenue Growth 0.092 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.